RH Likely To Report Q1 Loss; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call

Benzinga Earnings
06/11

RH (NYSE:RH) will release earnings for its first quarter after the closing bell on Thursday, June 11.

Analysts expect the Corte Madera, California-based company to report a quarterly loss of $2.07 per share, versus a profit of 13 cents per share in the year-ago period. The consensus estimate for RH's quarterly revenue is $792.38 million (it reported $813.95 million last year), according to Benzinga Pro.

On March 31, RH reported worse-than-expected fourth-quarter financial results and issued FY26 sales guidance below estimates.

RH shares fell 0.9% to close at $148.69 on Wednesday.

Benzinga readers can access the latest analyst ratings on the Analyst Stock Ratings page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.

Let's have a look at how Benzinga's most-accurate analysts have rated the company in the recent period.

  • UBS analyst Michael Lasser maintained a Neutral rating and cut the price target from $160 to $155 on June 9, 2026. This analyst has an accuracy rate of 75%.
  • Wells Fargo analyst Zachary Fadem maintained an Overweight rating and slashed the price target from $180 to $160 on May 14, 2026. This analyst has an accuracy rate of 72%.
  • Guggenheim analyst Steven Forbes maintained a Buy rating with a price target of $200 on April 27, 2026. This analyst has an accuracy rate of 51%.
  • Goldman Sachs analyst Kate McShane maintained a Sell rating and slashed the price target from $101 to $88 on April 7, 2026. This analyst has an accuracy rate of 69%.
  • Citigroup analyst Steven Zaccone maintained a Neutral rating and cut the price target from $183 to $150 on April 2, 2026. This analyst has an accuracy rate of 53%.

Considering buying RH stock? Here’s what analysts think:

Photo via Shutterstock

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10